STOCK TITAN

Geron to Participate in the Stifel 2024 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Geron (Nasdaq: GERN) announced its management team will participate in a fireside chat at the Stifel 2024 Healthcare Conference in New York City. The presentation is scheduled for Monday, November 18th, 2024, at 1:50pm ET.

The company will make a webcast of the fireside chat accessible through the Investors and Media section of Geron's website under Events. The webcast recording will remain available for replay for 30 days following the presentation.

Geron (Nasdaq: GERN) ha annunciato che il suo team di gestione parteciperà a una conversazione informale al Stifel 2024 Healthcare Conference a New York City. La presentazione è programmata per lunedì 18 novembre 2024, alle 13:50 ET.

L'azienda renderà disponibile il webcast della conversazione informale attraverso la sezione Investitori e Media del sito web di Geron, sotto Eventi. La registrazione del webcast rimarrà disponibile per il replay per 30 giorni dopo la presentazione.

Geron (Nasdaq: GERN) anunció que su equipo de gestión participará en una charla junto a la chimenea en la Stifel 2024 Healthcare Conference en Nueva York. La presentación está programada para el lunes 18 de noviembre de 2024, a la 1:50 p.m. ET.

La compañía hará que el webcast de la charla esté accesible a través de la sección de Inversores y Medios en el sitio web de Geron bajo Eventos. La grabación del webcast estará disponible para su reproducción durante 30 días después de la presentación.

Geron (Nasdaq: GERN)은 경영진 팀이 뉴욕에서 열리는 Stifel 2024 Healthcare Conference에서 파이어사이드 채팅에 참여한다고 발표했습니다. 발표는 2024년 11월 18일 월요일 오후 1시 50분 ET로 예정되어 있습니다.

회사는 Geron 웹사이트의 투자자 및 미디어 섹션 내 이벤트에 파이어사이드 채팅의 웹캐스트를 접근할 수 있도록 제공합니다. 웹캐스트 녹화는 발표 후 30일 동안 재생을 위해 제공됩니다.

Geron (Nasdaq: GERN) a annoncé que son équipe de direction participera à une discussion informelle lors de la Stifel 2024 Healthcare Conference à New York. La présentation est prévue pour le lundi 18 novembre 2024, à 13h50 ET.

L'entreprise rendra accessible le webcast de la discussion informelle via la section Investisseurs et Médias du site Web de Geron sous Événements. L'enregistrement du webcast sera disponible en replay pendant 30 jours après la présentation.

Geron (Nasdaq: GERN) kündigte an, dass sein Management-Team an einem Fireside-Chat auf der Stifel 2024 Healthcare Conference in New York City teilnehmen wird. Die Präsentation ist für Montag, den 18. November 2024, um 13:50 Uhr ET angesetzt.

Das Unternehmen wird den Webcast des Fireside-Chats über den Bereich Investoren und Medien auf der Website von Geron unter Veranstaltungen zugänglich machen. Die Aufzeichnung des Webcasts wird für 30 Tage nach der Präsentation für eine Wiederholung verfügbar sein.

Positive
  • None.
Negative
  • None.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced members of the management team are scheduled to participate in a fireside chat at the Stifel 2024 Healthcare Conference, in New York City, on Monday, November 18th, 2024, at 1:50pm ET.

A webcast of the fireside chat will be available through the Investors and Media section of Geron’s website under Events following the presentation. The webcast will be archived and available for replay for a period of 30 days.

About Geron

Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor RYTELO™ (imetelstat) is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion dependent anemia. We are also conducting a pivotal Phase 3 clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com or follow us on LinkedIn.

Aron Feingold

Vice President, Investor Relations and Corporate Communications

Kristen Kelleher

Associate Director, Investor Relations and Corporate Communications

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

When is Geron (GERN) presenting at the Stifel 2024 Healthcare Conference?

Geron (GERN) is scheduled to present at the Stifel 2024 Healthcare Conference on Monday, November 18th, 2024, at 1:50pm ET in New York City.

How long will the Stifel Conference webcast be available on Geron's (GERN) website?

The webcast will be archived and available for replay on Geron's website for 30 days following the presentation.

Where can I watch Geron's (GERN) Stifel 2024 Healthcare Conference presentation?

The webcast will be accessible through the Investors and Media section of Geron's website under Events.

What type of presentation will Geron (GERN) give at the Stifel 2024 Healthcare Conference?

Geron's management team will participate in a fireside chat format presentation at the conference.

Geron Corp

NASDAQ:GERN

GERN Rankings

GERN Latest News

GERN Stock Data

2.28B
604.50M
0.09%
78.63%
13.08%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
FOSTER CITY